Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Frontiers in Oncology
|
April 27, 2026
Clinical implementation of a one-step no-wash flow cytometry method allows for real-time monitoring of patients treated with autologous CAR-T cells
Nassim Salem, Clémence Demerlé, Bechara Mfarrej, et al.
Journal De Mycologie Medicale
|
January 16, 2026
Probable disseminated cryptococcosis relapse in a patient with Hodgkin's lymphoma treated with induction therapy resumption and autologous stem cell transplant
Hugo Bes-Berlandier, Jan Patrick Stellmann, Simar Berro, et al.
Bone Marrow Transplantation
|
November 4, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome
Samia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, et al.
Transplantation and Cellular Therapy
|
December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide
Jacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Bone Marrow Transplantation
|
November 16, 2020
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome
Luca Castagna, Thomas Pagliardini, Stefania Bramanti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients
Thomas Pagliardini, Lucas Castagna, Samia Harbi, et al.
Blood Advances
|
April 1, 2020
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma
Chiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, et al.
Cancer Medicine
|
October 18, 2016
Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS
Patrice Chevallier, Myriam Labopin, Regis Peffault de La Tour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 21, 2014
Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis
Marie Robin, Federica Giannotti, Eric Deconinck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy
Rémy Duléry, Mohamad Mohty, Alain Duhamel, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Frontiers in Oncology
|
April 27, 2026
Clinical implementation of a one-step no-wash flow cytometry method allows for real-time monitoring of patients treated with autologous CAR-T cells
Nassim Salem, Clémence Demerlé, Bechara Mfarrej, et al.
Journal De Mycologie Medicale
|
January 16, 2026
Probable disseminated cryptococcosis relapse in a patient with Hodgkin's lymphoma treated with induction therapy resumption and autologous stem cell transplant
Hugo Bes-Berlandier, Jan Patrick Stellmann, Simar Berro, et al.
Bone Marrow Transplantation
|
November 4, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome
Samia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, et al.
Transplantation and Cellular Therapy
|
December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide
Jacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Bone Marrow Transplantation
|
November 16, 2020
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome
Luca Castagna, Thomas Pagliardini, Stefania Bramanti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients
Thomas Pagliardini, Lucas Castagna, Samia Harbi, et al.
Blood Advances
|
April 1, 2020
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma
Chiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, et al.
Cancer Medicine
|
October 18, 2016
Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS
Patrice Chevallier, Myriam Labopin, Regis Peffault de La Tour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 21, 2014
Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis
Marie Robin, Federica Giannotti, Eric Deconinck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy
Rémy Duléry, Mohamad Mohty, Alain Duhamel, et al.
Page
of 4